Oyster Bay, New York - 13 Oct 2016
This year, the global diabetic population crossed half a billion, and it continues to grow. In response, device manufacturers, healthcare providers, and patients are looking for ways to manage this long-term chronic disease in an efficient and unobtrusive way. In its examination of both current and in-development technologies geared toward extending effective diabetes care, ABI Research finds wearable continuous glucose monitoring devices are paramount. Between now and 2021, more than nine million wearable CGM devices will ship, as they increasingly gain support and challenge finger prick glucose meters.
“mHealth wearable device manufacturers integrated the new, non-invasive CGMs and insulin pumps with cloud services, analytics tools, and predictive software to provide new types of pattern analysis in near real time,” says Ryan Harbison, Research Analyst at ABI Research.
The overall diabetic testing market, which includes glucose meters and test strips, will exceed $17 billion in 2021, up from $12 billion in 2016. CGM revenues will grow at a CAGR of 41% over the same period. Existing glucose meter device vendors, such as Bayer and Johnson & Johnson, will increasingly have to compete against CGM specialists, including Abbott, Dexcom, and Medtronic.
“Medtronic has a substantial advantage with its MiniMed CGM system, Abbott focuses on the European market, and Dexcom innovates on existing CGM devices to create all-in-one experiences through mobile integrations,” concludes Harbison. “Glucose meter manufacturers, such as Johnson & Johnson and Roche Diagnostics, can further disrupt this market by developing new form factors, such as contact lenses and skin patches, to create less invasive and more accurate monitoring devices.”
These findings are from ABI Research’s Diabetes: Wearable mHealth Device Market Overview. This report is part of the company’s Smart Home and Wearables & Devices sectors, which include research, data, and analyst insights.
About ABI Research
ABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors.
ABI Research提供开创性的研究和战略指导，帮助客户了解日新月异的技术。 自1990年以来，我们已与全球数百个领先的技术品牌，尖端公司，具有远见的政府机构以及创新的贸易团体建立了合作关系。 我们帮助客户创造真实的业务成果。
For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.
Asia: +65 6950.5670